Objectives-Falls are highly prevalent in individuals with cognitive decline. The complex relationship between falls and cognitive decline (including both subtype and severity of dementia) and the influence of gait disorders have not been studied. This study aimed to examine the association between the subtype (Alzheimer disease [AD] versus non-AD) and the severity (from preclinical to moderate dementia) of cognitive impairment and falls, and to establish an association between falls and gait parameters during the course of dementia.
Falls affect more than 30% of older adults 1 and represent a leading cause of hospitalization, morbidity, disability, and mortality. 2 Cognitive impairment has been identified as a risk factor for falls in aging. 3, 4 Impaired executive function, but not memory impairment, has been associated with increased prevalence of falls in healthy older adults. 3 Dementia is considered an independent risk factor for falling in older adults. 5, 6 Older adults with dementia fall 2 to 3 times more than cognitively healthy older adults. 7 The progression of white matter changes 8 and subcortical infarcts 9 have been associated with increased risk of falling. The influence of the subtype (ie, Alzheimer disease [AD] versus non-AD) and the severity (ie, from preclinical to severe) of dementia on fall risk, however, have not yet been identified.
The use of quantitative gait parameters improves the identification of people who fall among older adults with dementia, as reduced gait speed and stride length predict the short-term occurrence of falls in older adults with mild to moderate dementia. 10 Among quantitative gait parameters, in addition to gait speed, stride time variability (ie, coefficient of variability of stride time), a marker of higher level of gait control, 11-13 also has been suggested as an appropriate biomarker of fall risk. [14] [15] [16] An association between quantitative gait (ie, gait speed or stride time variability) parameters and falls across the subtypes and the severity of dementia from normal aging to moderate stage of dementia, however, has not been established.
To address these issues, we examined the database of a cross-sectional multicentric study called the "Gait, cOgnitiOn & Decline" (GOOD) initiative that includes more than 2700 older adults with and without dementia. 17, 18 This analysis aimed to explore the association between the subtype of dementia as well as the severity of cognitive impairment and falls, and to establish the association between falls and quantitative gait parameters during the course of dementia. We hypothesized that (1) more severe cognitive impairment and non-AD subtype of dementia would be associated with increased prevalence of falls, and (2) the influence of poor gait would be associated with falls in the non-AD subtype, and the more advanced stage of dementia. Establishing the influence of subtype and severity of cognitive impairment on falls can help to better understand the neural basis of falls and to improve our fall prevention strategy in aging.
Methods

Study Design and Population
This cross-sectional study included data from the GOOD initiative, a consortium from 7 countries (ie, Australia, Belgium, France, India, Luxembourg, Switzerland, and the United States). The characteristics and the aims of the GOOD initiative have been previously detailed. 17 Briefly, the GOOD initiative recruits community-dwelling individuals or patients with and without dementia from the Tasmanian Study of Cognition and Gait (TASCOG; community-dwelling individuals) (Menzies Institute for Medical Research, Hobart, southern Tasmania, Australia), from Mechelen memory clinic (outpatients with cognitive complaints), from the "Gait and Alzheimer Interactions Tracking" (GAIT) study Angers memory clinic (community-dwelling individuals and outpatients with cognitive complaints), from the Kerala-Einstein Study (KES) (Kozhikode city, Kerala, India, outpatients), from the Center for Memory and Mobility (Luxembourg city, Luxembourg, outpatients and inpatients with cognitive complaints), from the Central Control of Mobility in Aging (CCMA, communitydwelling individuals) (New York, lower Westchester county, USA), and from the Basel mobility center (University Center for Medicine of Aging Basel, Felix Platter Hospital, Basel, outpatients with cognitive complaints). Inclusion criteria for the present analysis were participants older than 60 years, participants able to walk without personal assistance, information on previous falls (yes or no), information on clinical characteristics and cognitive status (ie, cognitively healthy individuals [CHIs], patients with amnestic mild cognitive impairment [aMCI] and nonamnestic MCI [naMCI], or mild and moderate AD or non-AD dementia), and gait assessment with the GAITRite system. From the 2717 participants initially recruited, we excluded 221 because spatiotemporal parameters, clinical characteristics, or cognitive status were missing. After exclusions, a total of 2496 participants (76.6 ± 7.6 years; 55% women) were included in the present analysis. The ethics committee of Angers University Hospital approved the GOOD initiative. Furthermore, each center involved in the GOOD initiative obtained individual approval from their local ethics committee. Clinical trials registration number is NCT02350270.
Gait Measurements
Spatiotemporal gait parameters were measured at steady-state walking using the GAITRite system in each center. The participants walked at their usual self-selected walking speed in a quiet, well-lit environment wearing their own footwear. The GAITRite system is an instrumented walkway with a length ranging from 4.6 m (TASCOG study) to 7.9 m (GAIT study) recording area. Participants walked for 1 trial in all cohorts except in the TASCOG study (6 trials) . The mean values from the 6 trials in TASCOG were used for the analysis. Based on previous studies reporting gait parameters associated with falls in older adults, 1, 16 we included gait speed, cadence, stride time, stride length, support base, swing time, stance time, and single support time for this analysis. Coefficients of variation (CoV) of spatiotemporal gait parameters were calculated following the following formula: CoV = (SD/mean) × 100.
Falls Assessments
A fall was defined as unintentionally coming down to the floor or lower level not due to a major intrinsic or extrinsic event. 19 Self-reported retrospective falls were recorded based on the presence of any fall in the previous 12 months with a standardized questionnaire in the CCMA, GAIT, KES, and the TASCOG studies, as well in the Basel mobility center and the Mechelen memory clinic; in the Center for Memory and Mobility in Luxembourg, retrospective falls were recorded on the occurrence of falls in the previous 6 months.
Dementia and Cognitive Assessments
Participants were classified into each diagnostic group based on a comprehensive neuropsychological assessment: CHI, aMCI, naMCI, mild AD, mild non-AD, moderate AD, and moderate non-AD. CHIs presented normal cognitive tests in all cognitive domains with scores at -1.5 SDs or above the age-appropriate means (higher scores better). Amnestic MCI and naMCI were assigned if the participants reported spontaneous cognitive complaints and presented an objective impairment respectively in the memory or the nonmemory domains (ie, defined as a score at -1.5 SDs or below the age-appropriate mean), with preservation of independence in functional abilities. 20 We dichotomized the MCI group into aMCI and naMCI: participants were classified as aMCI when memory loss was the only deficit; and as naMCI when a cognitive domain other than memory was disturbed and/or if memory loss was combined with impairment in other cognitive domains. Dementia (AD and non-AD subtypes) and MCI (aMCI and naMCI) were diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) at consensus diagnostic case conferences in all centers, except in the TASCOG study: self-report, review of medical history, cognitive testing, and/or clinical interview were used to diagnose dementia. The severity of dementia (mild and moderate stages) was defined by a Mini-Mental Status Examination (MMSE) score ≥20 and a Clinical Dementia Rating (CDR) score of 1 for the mild stage; and by an MMSE between 19 and 10, CDR score of 2 for the moderate stage.
Covariates
Age, gender, education coded as a binary variable (ie, high school level yes versus no), number of drugs, psychoactive drugs (ie, benzodiazepines or antidepressants or neuroleptics), depressive symptoms, and study center were used as covariates, as these variables were previously associated with falls, 19, 21, 22 and were available in all individual cohorts. Depressive symptoms were assessed with the 4-item, the 15-item, or the 30-item Geriatric Depression Scale (score ≥1 or ≥5 or ≥10 indicated the presence of depressive symptoms, respectively). 23 Allali et al. 
Results
Clinical characteristics of individuals who fall and those who do not fall, including spatiotemporal gait parameters, are presented in Table 1 . Individuals who fall were older, more likely to be women, were less educated, and were taking more drugs than those who do not fall. The prevalence of depression is double in the group of those who fall. The prevalence of people who fall was higher in all dementia subgroups. The prevalence of those who fall in CHIs was 25%, in MCI 31%, and in dementia 55% (50% in AD and 64% in non-AD (Table 2) . When combining aMCI and naMCI in one group (MCI group) and both subtypes and level of severity of dementia in another group (dementia group), the patients with dementia fell more than CHIs (OR 1.49; 95% CI 1.10-2.01; P = .010), whereas MCI participants fell at the same range as the CHIs (OR 1.04; 95% CI 0.80-1.37; P = .753), after adjusting for covariates. When combining mild and moderate AD dementia in one group (AD group) and mild and moderate non-AD dementia in another group (non-AD group), non-AD patients fell more than CHIs (OR 2.31; 95% CI 1.56-3.42; P < .001), whereas patients with AD fell at the same range as the CHIs (OR 1.15; 95% CI 0.80-1.65; P =.446), after adjusting for covariates.
Regarding the association between gait parameters and falls, higher stride time variability (STV) was associated with falling in CHI, aMCI, naMCI, and mild non-AD participants, but not in the other groups (Table 3) . For gait speed, falling was associated with slower gait speed for every group, except for mild AD (after adjustment) ( speed and STV in the same model, both higher STV and slower gait speed were associated with falling in CHIs, whereas in the pathological groups, only slower gait speed was associated with fall in naMCI, moderate AD, and non-AD dementia (Table 5) .
Discussion
We investigated the association of subtype and severity of dementia with falls and the role of poor gait on falls across the spectrum and the subtype of dementia. We found that patients with non-AD dementia, but not AD dementia, had more than twice the prevalence of falls than CHIs. Regarding gait parameters, those who fall in the CHI, aMCI, naMCI, and mild non-AD dementia groups presented with higher STV in comparison with those who do not fall, whereas the other groups presented similar STV. Those who fall in all groups, except in mild AD dementia, had slower gait speed in comparison with those who do not fall. When STV was adjusted for gait speed, only the CHIs who fall presented with higher STV in comparison with those who do not fall, whereas those who fall in the MCI and the dementia groups presented a similar STV than those, who do not fall.
Non-AD patients had a previous fall twice more than healthy older adults, whereas patients with AD had a previous fall at the similar range than healthy older adults. This increased falls rate in non-AD dementia is in accordance with previous studies: an increased prevalence of fall-related injury was reported in patients with dementia with Lewy bodies (DLB) (10.7%) than in AD (1.1%). 24 Multiple falls occurred in 37% of patients with DLB in comparison with 6% of patients with AD. 25 Regarding the similar falls rate between patients with AD and CHIs, a previous report suggests that the increased prevalence of falls in patients with AD may be explained by the use of neuroleptics and the presence of white matter changes. 26 However, amyloid deposition (assessed by the Pittsburgh compound B positron emission tomography and cerebrospinal fluid tau, phosphotau, and Aβ42 biomarker) predicts falls in cognitively healthy older adults. 27 These findings in combination with the results of the current study suggest that the pathophysiological mechanisms of falls in AD differ between the early course and the more advanced stages of the disease: "silent" amyloid deposition playing a role in the preclinical stage, whereas other factors, such as adverse events of medication or white matters changes, in the later stages. 6, 26, 28 The contribution of gait parameters to fall risk, especially STV, that reflects the highest level of gait control, differs between CHIs and patients with MCI or dementia: increased STV is associated with CHIs who fall, and those who fall in the earliest form of cognitive decline (MCI and mild dementia). When adjusted for gait speed, STV is higher only in CHIs who fall, but not in patients with MCI or dementia who fall. Increased STV is associated with gait instability [13] [14] [15] and is considered an appropriate biomarker of risk of falls, even better than gait speed. 15, 29, 30 STV has been associated with frontal lobe functions in healthy older adults, 31, 32 in patients with MCI, 33, 34 and in dementias. 17, [34] [35] [36] [37] [38] Neuroimaging studies suggest that STV is also associated with hippocampal volumes. 11, 39 Interestingly, this association differs between CHIs and patients with early signs of cognitive decline, 11 suggesting that different brain structures are involved in higher levels of gait control in older adults with intact cognition and those with impaired cognitive functions. These different brain regions associated with the highest level of gait control in healthy older adults and in patients with impaired cognition could explain this different contribution of STV in falls between CHIs and patients with MCI or dementia. Alternate explanation could refer to the fact that in comparison with CHIs, specific risk factors for falls in dementia have been identified, such as the presence of DLB or the duration of dementia. 40 Furthermore, by comparing risk factors for falls between nursing home residents with and without dementia, the discrepancy of the degree of explanation of the variation of falls between residents with and without dementia (25.5% in residents with dementia versus 54.8% in those without dementia) suggests different risk factors for falls between elders with and without dementia. 41 Including such a high number of participants with and without dementia from various countries represents the main strength of this study. Furthermore, this is the first study that includes a comparison of the association of quantitative gait parameters and falls in more than 2000 participants separated by subtypes and stages of dementia. Some limitations should be acknowledged, however: (1) we used retrospective fall recording that is not considered the best approach for fall assessment, and (2) although the proportion of those who fall is much higher in participants with dementia, recall bias could still affect reporting, especially in participants with cognitive impairment. Nevertheless, potential recall bias is likely to result in underestimate of associations with cognitively impaired participants' underreporting falls. Although we dichotomized participants between AD and non-AD subtypes according to DSM-IV, we do not have an autopsy-confirmed diagnosis. Finally, even if we included the major covariates known to be associated with falls in our regressions, we were not able to include all the risk factors, due to the heterogeneity of the various cohorts.
Conclusion
In conclusion, this study confirms that older adults with dementia fall more than healthy older adults, but this was found for non-Alzheimer-type dementia, rather than AD-type dementia. Regarding the association between falls and quantitative gait parameters, higher (ie, worst performance) STV was associated with falls only in healthy older adults, suggesting that other risk factors contribute to falls in older adults with dementia. Future prospective study including older adults without dementia and people with different stages and subtypes of dementia should confirm these findings. 
